The stock of PepGen Inc (NASDAQ: PEPG) has increased by 167.49 when compared to last closing price of 1.37.Despite this, the company has seen a gain of 188.55% in its stock price over the last five trading days. businesswire.com reported 2025-02-24 that BOSTON–(BUSINESS WIRE)–PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the quarter and year-ended December 31, 2024, and recent corporate highlights. “Today, we reported initial results from FREEDOM-DM1, which showed robust splicing correction in patients with DM1 following a single dos.
Is It Worth Investing in PepGen Inc (NASDAQ: PEPG) Right Now?
The 36-month beta value for PEPG is at 1.50. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for PEPG is 27.18M, and currently, shorts hold a 2.49% of that float. The average trading volume for PEPG on February 24, 2025 was 315.65K shares.
PEPG’s Market Performance
PEPG’s stock has seen a 188.55% increase for the week, with a 87.93% rise in the past month and a -18.02% fall in the past quarter. The volatility ratio for the week is 9.77%, and the volatility levels for the past 30 days are at 11.72% for PepGen Inc The simple moving average for the past 20 days is 140.54% for PEPG’s stock, with a -59.50% simple moving average for the past 200 days.
Analysts’ Opinion of PEPG
Many brokerage firms have already submitted their reports for PEPG stocks, with BofA Securities repeating the rating for PEPG by listing it as a “Underperform.” The predicted price for PEPG in the upcoming period, according to BofA Securities is $3 based on the research report published on December 16, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see PEPG reach a price target of $12. The rating they have provided for PEPG stocks is “Neutral” according to the report published on July 31st, 2024.
H.C. Wainwright gave a rating of “Buy” to PEPG, setting the target price at $26 in the report published on December 21st of the previous year.
PEPG Trading at 33.73% from the 50-Day Moving Average
After a stumble in the market that brought PEPG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.01% of loss for the given period.
Volatility was left at 11.72%, however, over the last 30 days, the volatility rate increased by 9.77%, as shares surge +108.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.28% lower at present.
During the last 5 trading sessions, PEPG rose by +218.11%, which changed the moving average for the period of 200-days by -71.04% in comparison to the 20-day moving average, which settled at $1.5423. In addition, PepGen Inc saw -3.31% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PEPG starting from Mellion Michelle L, who sale 7,571 shares at the price of $18.06 back on Jul 25 ’24. After this action, Mellion Michelle L now owns 0 shares of PepGen Inc, valued at $136,741 using the latest closing price.
Mellion Michelle L, the Chief Medical Officer of PepGen Inc, sale 201 shares at $18.01 during a trade that took place back on Jul 24 ’24, which means that Mellion Michelle L is holding 0 shares at $3,619 based on the most recent closing price.
Stock Fundamentals for PEPG
Current profitability levels for the company are sitting at:
- -56.75 for the present operating margin
- 0.34 for the gross margin
The net margin for PepGen Inc stands at -52.55. The total capital return value is set at -0.61. Equity return is now at value -66.26, with -52.16 for asset returns.
Based on PepGen Inc (PEPG), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -4.32. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -49.61.
Currently, EBITDA for the company is -83.58 million with net debt to EBITDA at 0.25. When we switch over and look at the enterprise to sales, we see a ratio of 53.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.47.
Conclusion
In conclusion, PepGen Inc (PEPG) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
